Published in Oncogene on June 27, 2011
Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma. Nat Rev Cancer (2013) 2.87
Hepatitis B virus X protein-induced aberrant epigenetic modifications contributing to human hepatocellular carcinoma pathogenesis. Mol Cell Biol (2013) 1.10
Environmental epigenetics and its implication on disease risk and health outcomes. ILAR J (2012) 1.10
Hepatocyte polarity. Compr Physiol (2013) 1.06
Hepatitis B virus X protein accelerates the development of hepatoma. Cancer Biol Med (2014) 1.04
Hedgehog signaling blockade delays hepatocarcinogenesis induced by hepatitis B virus X protein. Cancer Res (2012) 0.96
Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation. Carcinogenesis (2013) 0.92
Akt mediates metastasis-associated gene 1 (MTA1) regulating the expression of E-cadherin and promoting the invasiveness of prostate cancer cells. PLoS One (2012) 0.92
Hepatitis C virus induces epithelial-mesenchymal transition in primary human hepatocytes. J Virol (2012) 0.90
Human tumour viruses and the deregulation of cell polarity in cancer. Nat Rev Cancer (2012) 0.90
HBx-upregulated lncRNA UCA1 promotes cell growth and tumorigenesis by recruiting EZH2 and repressing p27Kip1/CDK2 signaling. Sci Rep (2016) 0.82
Diverse functions of miR-373 in cancer. J Transl Med (2015) 0.82
MicroRNAs associated with HBV infection and HBV-related HCC. Theranostics (2014) 0.81
New horizon for radical cure of chronic hepatitis B virus infection. World J Hepatol (2016) 0.79
Hepatitis B virus X protein-mediated non-coding RNA aberrations in the development of human hepatocellular carcinoma. Exp Mol Med (2017) 0.77
Hepatitis B Virus X Protein and Hepatocarcinogenesis. Int J Mol Sci (2016) 0.76
Induction of VEGFA and Snail-1 by meningitic Escherichia coli mediates disruption of the blood-brain barrier. Oncotarget (2016) 0.76
The regulation of proteins associated with the cytoskeleton by hepatitis B virus X protein during hepatocarcinogenesis. Oncol Lett (2017) 0.75
HBX Protein-Induced Downregulation of microRNA-18a is Responsible for Upregulation of Connective Tissue Growth Factor in HBV Infection-Associated Hepatocarcinoma. Med Sci Monit (2016) 0.75
Progressive Enrichment of Stemness Features and Tumor Stromal Alterations in Multistep Hepatocarcinogenesis. PLoS One (2017) 0.75
MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet (2004) 37.83
The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol (2000) 15.78
Cadherin cell adhesion receptors as a morphogenetic regulator. Science (1991) 13.78
Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell (2009) 11.65
Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet (1999) 9.53
A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature (1998) 8.48
TGF-beta-induced epithelial to mesenchymal transition. Cell Res (2009) 7.88
Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med (2004) 6.48
MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci U S A (2008) 6.38
The role of epithelial-mesenchymal transition in cancer pathology. Pathology (2007) 5.16
Activating gene expression in mammalian cells with promoter-targeted duplex RNAs. Nat Chem Biol (2007) 5.05
Small dsRNAs induce transcriptional activation in human cells. Proc Natl Acad Sci U S A (2006) 4.90
Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions. J Biol Chem (2003) 4.55
Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex. Mol Cell Biol (2004) 4.15
Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci (2007) 4.07
Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway. Nature (1993) 3.88
The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci (2008) 3.77
Epithelial-mesenchymal transition in cancer development and its clinical significance. Cancer Sci (2009) 3.39
The role of histone deacetylases (HDACs) in human cancer. Mol Oncol (2007) 2.72
In vivo dual cross-linking for identification of indirect DNA-associated proteins by chromatin immunoprecipitation. Biotechniques (2006) 2.46
Cell adhesion system and human cancer morphogenesis. Cancer Sci (2003) 2.18
Epigenetic modification induced by hepatitis B virus X protein via interaction with de novo DNA methyltransferase DNMT3A. J Hepatol (2008) 1.95
Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-kappa B via oxidative stress. Mol Cell Biol (2001) 1.93
Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential. FASEB J (2004) 1.84
Hepatitis B virus-induced oncogenesis. World J Gastroenterol (2007) 1.82
Transcriptional repressor snail and progression of human hepatocellular carcinoma. Clin Cancer Res (2003) 1.79
Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein. Gastroenterology (2007) 1.68
Inverse correlation between E-cadherin and Snail expression in hepatocellular carcinoma cell lines in vitro and in vivo. Br J Cancer (2002) 1.66
The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas. Int J Cancer (1997) 1.64
Histone deacetylase inhibitor Trichostatin A induces global and gene-specific DNA demethylation in human cancer cell lines. Biochem Pharmacol (2007) 1.56
Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival. Hum Pathol (2000) 1.42
Role of E boxes in the repression of E-cadherin expression. Biochem Biophys Res Commun (1997) 1.37
Hepatitis B virus X protein represses E-cadherin expression via activation of DNA methyltransferase 1. Oncogene (2005) 1.34
Regulation of transforming growth factor-beta 1 expression by the hepatitis B virus (HBV) X transactivator. Role in HBV pathogenesis. J Clin Invest (1996) 1.33
Clinical significance of histone deacetylase 1 expression in patients with hepatocellular carcinoma. Oncology (2007) 1.33
Hepatitis B virus X protein induces the expression of MTA1 and HDAC1, which enhances hypoxia signaling in hepatocellular carcinoma cells. Oncogene (2008) 1.32
Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer. Cancer Res (1991) 1.25
E-cadherin is involved in the intrahepatic metastasis of hepatocellular carcinoma. Hepatology (1996) 1.24
pX, the HBV-encoded coactivator, interacts with components of the transcription machinery and stimulates transcription in a TAF-independent manner. EMBO J (1996) 1.24
Phosphorylation of serine 11 and serine 92 as new positive regulators of human Snail1 function: potential involvement of casein kinase-2 and the cAMP-activated kinase protein kinase A. Mol Biol Cell (2009) 1.21
HBxAg in the liver from carrier patients with chronic hepatitis and cirrhosis. Hepatology (1991) 1.19
The hepatitis B virus encoded oncoprotein pX amplifies TGF-beta family signaling through direct interaction with Smad4: potential mechanism of hepatitis B virus-induced liver fibrosis. Genes Dev (2001) 1.17
Downregulation of E-cadherin by hepatitis B virus X antigen in hepatocellullar carcinoma. Oncogene (2006) 1.15
Cytosol is the prime compartment of hepatitis B virus X protein where it colocalizes with the proteasome. Oncogene (1998) 1.10
Direct association and nuclear import of the hepatitis B virus X protein with the NF-kappaB inhibitor IkappaBalpha. Mol Cell Biol (1999) 1.09
Chronic hepatitis B in hepatocarcinogenesis. Postgrad Med J (2006) 1.07
E-cadherin expression in patients with esophageal squamous cell carcinoma: promoter hypermethylation, Snail overexpression, and clinicopathologic implications. Am J Clin Pathol (2004) 1.05
Presence of antibodies to the polymerase gene product(s) of hepatitis B and woodchuck hepatitis virus in natural and experimental infections. J Med Virol (1988) 1.03
The translation initiation factor, hu-Sui1 may be a target of hepatitis B X antigen in hepatocarcinogenesis. Oncogene (1999) 1.02
Hepatitis B virus HBx protein localized to the nucleus restores HBx-deficient virus replication in HepG2 cells and in vivo in hydrodynamically-injected mice. Virology (2009) 1.00
Enhanced cell survival of Hep3B cells by the hepatitis B x antigen effector, URG11, is associated with upregulation of beta-catenin. Hepatology (2006) 0.99
microRNAs, RNA binding proteins and cancer. Eur J Clin Invest (2010) 0.97
Hepatitis B virus-X protein recruits histone deacetylase 1 to repress insulin-like growth factor binding protein 3 transcription. Virus Res (2008) 0.91
Human hepatitis B virus X protein is detectable in nuclei of transfected cells, and is active for transactivation. Biochim Biophys Acta (1999) 0.88
Hepatitis B virus X antigen promotes transforming growth factor-beta1 (TGF-beta1) activity by up-regulation of TGF-beta1 and down-regulation of alpha2-macroglobulin. J Gen Virol (2004) 0.84
Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc Natl Acad Sci U S A (1994) 3.76
Management of deliberate self poisoning in adults in four teaching hospitals: descriptive study. BMJ (1998) 3.68
Women's experiences of general practitioner management of miscarriage. J R Coll Gen Pract (1989) 2.72
Structural relationships between the surface antigens of ground squirrel hepatitis virus and human hepatitis B virus. J Virol (1980) 2.20
Effects of thermal discomfort in an office on perceived air quality, SBS symptoms, physiological responses, and human performance. Indoor Air (2011) 2.00
Functional inactivation but not structural mutation of p53 causes liver cancer. Nat Genet (1995) 1.80
Prognostic significance of serum vascular endothelial growth factor and endostatin in patients with hepatocellular carcinoma. Br J Surg (2004) 1.62
Antigenic and structural relationships of the surface antigens of hepatitis B virus, ground squirrel hepatitis virus, and woodchuck hepatitis virus. J Virol (1981) 1.61
Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA. EMBO J (1990) 1.54
The nature of polypeptides larger in size than the major surface antigen components of hepatitis b and like viruses in ground squirrels, woodchucks, and ducks. Virology (1983) 1.46
Immunofluorescent localization of Tamm-Horsfall mucoprotein. Experientia (1966) 1.40
Care of women with puerperal psychiatric disorders in England and Wales. BMJ (1991) 1.39
Cholestatic jaundice caused by sequential carbimazole and propylthiouracil treatment for thyrotoxicosis. Hong Kong Med J (2003) 1.38
Major polypeptide of duck hepatitis B surface antigen particles. J Virol (1983) 1.32
Early screening for amblyogenic risk factors lowers the prevalence and severity of amblyopia. J AAPOS (2000) 1.31
Pragmatic randomized trial of antenatal intervention to prevent post-natal depression by reducing psychosocial risk factors. Psychol Med (2000) 1.26
Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer. Cancer Res (1991) 1.25
HBxAg in the liver from carrier patients with chronic hepatitis and cirrhosis. Hepatology (1991) 1.19
A newly identified hepatitis B type virus in tree squirrels. Proc Natl Acad Sci U S A (1986) 1.18
Association of BANK1 and TNFSF4 with systemic lupus erythematosus in Hong Kong Chinese. Genes Immun (2009) 1.15
Downregulation of E-cadherin by hepatitis B virus X antigen in hepatocellullar carcinoma. Oncogene (2006) 1.15
Outcome of fertility-preserving treatment in young women with endometrial carcinomas. BJOG (2005) 1.13
Depression in palliative care patients--a prospective study. Eur J Cancer Care (Engl) (2001) 1.10
A survey of psychosocial service provision within hospices. Palliat Med (1999) 1.10
An analysis of the validity of the Hospital Anxiety and Depression scale as a screening tool in patients with advanced metastatic cancer. J Pain Symptom Manage (2001) 1.10
Hypoxanthine: guanine phosphoribosyltransferase mutants in Saccharomyces cerevisiae. Mol Gen Genet (1983) 1.09
Direct interaction with contactin targets voltage-gated sodium channel Na(v)1.9/NaN to the cell membrane. J Biol Chem (2001) 1.08
A survey of antidepressant prescribing in the terminally ill. Palliat Med (1999) 1.08
Hepatitis B virus transgenic mouse model of chronic liver disease. Nat Med (1999) 1.06
Products of the "X" gene in hepatitis B and related viruses. Hepatology (1986) 1.04
Psychopathology in patients with endogenous Cushing's syndrome: 'atypical' or melancholic features. Clin Endocrinol (Oxf) (1995) 1.03
Candidate Neisseria meningitidis NspA vaccine. J Biotechnol (2000) 1.03
The translation initiation factor, hu-Sui1 may be a target of hepatitis B X antigen in hepatocarcinogenesis. Oncogene (1999) 1.02
Identification of a protein isolated from senescent human cells that binds to hepatitis B virus X antigen. Hepatology (1998) 1.02
Criterion validation of the Edinburgh postnatal depression scale as a screening tool for depression in patients with advanced metastatic cancer. J Pain Symptom Manage (2000) 1.01
Characterization of PCP-2, a novel receptor protein tyrosine phosphatase of the MAM domain family. Oncogene (1996) 1.00
Association of CD247 with systemic lupus erythematosus in Asian populations. Lupus (2011) 0.98
An examination of the accident and emergency management of deliberate self harm. J Accid Emerg Med (1997) 0.96
Interactions between alcohol and hepatitis viruses in the liver. Clin Lab Med (1996) 0.96
Sensitization of rhabdo-, lenti-, and spumaviruses to human serum by galactosyl(alpha1-3)galactosylation. J Virol (1997) 0.94
Hepatitis B virus X protein protects against anti-Fas-mediated apoptosis in human liver cells by inducing NF-kappa B. J Gen Virol (2001) 0.93
4-Aminobiphenyl DNA damage in liver tissue of hepatocellular carcinoma patients and controls. Am J Epidemiol (1998) 0.93
Control strategies of malaria in Henan Province, China. Southeast Asian J Trop Med Public Health (1999) 0.91
Burns and diabetes. Ann Burns Fire Disasters (2005) 0.91
Novel transcribed regions in the human genome. Cold Spring Harb Symp Quant Biol (2006) 0.91
Dickkopf 4 (DKK4) acts on Wnt/β-catenin pathway by influencing β-catenin in hepatocellular carcinoma. Oncogene (2012) 0.90
A cellular gene up-regulated by hepatitis B virus-encoded X antigen promotes hepatocellular growth and survival. Hepatology (2001) 0.90
The value of hepatitis B x antigen as a prognostic marker in the development of hepatocellular carcinoma. Int J Cancer (1993) 0.90
General hospital services for deliberate self-poisoning: an expensive road to nowhere? Postgrad Med J (1999) 0.89
Optimal protocol for total body irradiation for allogeneic bone marrow transplantation in mice. Bone Marrow Transplant (2002) 0.89
Giant papillary conjunctivitis following cataract extraction. Ann Ophthalmol (1984) 0.88
Tryptic peptide mapping of picomolar quantities of protein labeled with the Bolton--Hunter reagent. Anal Biochem (1981) 0.88
Attenuation of telomerase activity by a hammerhead ribozyme targeting the template region of telomerase RNA in endometrial carcinoma cells. Cancer Res (1998) 0.87
Integrity of p53 in hepatitis B x antigen-positive and -negative hepatocellular carcinomas. Cancer Res (1997) 0.87
Stimulatory effects of hepatocyte growth factor on hemopoiesis of SCF/c-kit system-deficient mice. Stem Cells (1998) 0.87
National survey on prevalence of cancer pain. Chin Med Sci J (2001) 0.87
Development of mouse dendritic cells from lineage-negative c-kit(low) pluripotent hemopoietic stem cells in vitro. Stem Cells (2000) 0.86
The use of psychoactive substances among adolescent students in an area in the south-west of China. Addiction (2001) 0.86
Telomerase activity in the female reproductive tract and neoplasms. Gynecol Oncol (1998) 0.86
Maintenance of the hydrophobic face of the diphtheria toxin amphipathic transmembrane helix 1 is essential for the efficient delivery of the catalytic domain to the cytosol of target cells. Protein Eng (1994) 0.86
Tree squirrel hepatitis B virus: antigenic and structural characterization. Proc Natl Acad Sci U S A (1986) 0.85
Preventive effects of Juzen-taiho-to on N-methyl-N-nitrosourea and estradiol-17beta-induced endometrial carcinogenesis in mice. Carcinogenesis (2001) 0.84
Characteristics of hepatitis B X antigen, antibodies to X antigen, and antibodies to the viral polymerase during hepatitis B virus infection. J Infect Dis (1991) 0.84
Chronic ethanol consumption stimulates hepatitis B virus gene expression and replication in transgenic mice. Hepatology (2001) 0.84
GSK3 inhibitor-BIO regulates proliferation of female germline stem cells from the postnatal mouse ovary. Cell Prolif (2012) 0.84
Xenotransplantation--state of the art--update 1999. Front Biosci (1999) 0.83
RNA interference-mediated URG4 gene silencing diminishes cyclin D1 mRNA expression in HepG2 cells. Genet Mol Res (2010) 0.83
Fate of allogeneic or syngeneic cells in intravenous or portal vein injection: possible explanation for the mechanism of tolerance induction by portal vein injection. Eur J Immunol (1994) 0.83
Evidence for migration of donor bone marrow stromal cells into recipient thymus after bone marrow transplantation plus bone grafts: A role of stromal cells in positive selection. Exp Hematol (2000) 0.82
Use of SV40 to immunize against hepatitis B surface antigen: implications for the use of SV40 for gene transduction and its use as an immunizing agent. Gene Ther (1998) 0.82
Activation of fibronectin gene expression by hepatitis B virus x antigen. J Viral Hepat (2004) 0.82
Two missense variants in UHRF1BP1 are independently associated with systemic lupus erythematosus in Hong Kong Chinese. Genes Immun (2011) 0.82
Drug dependence and abuse potential of tramadol. Zhongguo Yao Li Xue Bao (1999) 0.81
Hepatocyte-specific activation of NF-kappaB does not aggravate chemical hepatocarcinogenesis in transgenic mice. J Pathol (2009) 0.81
Imaging features of hepatic angiomyolipomas. J Med Imaging Radiat Oncol (2008) 0.81
Costs of antidepressant overdose: a preliminary study. Br J Gen Pract (1999) 0.80
Liver graft-versus-host disease after donor lymphocyte infusion for relapses of hematologic malignancies post allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant (2004) 0.80
A strategy for organ allografts without using immunosuppressants or irradiation. Proc Natl Acad Sci U S A (1998) 0.79
Hepatic resection for colorectal liver metastases: prospective study. Hong Kong Med J (2002) 0.79
X-ray tomography for structural analysis of microstructured and multimaterial optical fibers and preforms. Opt Express (2014) 0.78
Distress caused by miscarriage. Br J Psychiatry (1989) 0.78
Drunken patients in the general hospital: their care and management. Postgrad Med J (2005) 0.78
Gene therapy for pediatric brain tumors. Semin Pediatr Neurol (1997) 0.78
Heart rate variation and electroencephalograph--the potential physiological factors for thermal comfort study. Indoor Air (2009) 0.78
The clinical and epidemiological significance of serum PreS1/anti-PreS1 in HBV infection. Chin Med J (Engl) (1999) 0.78
[Computed tomography and magnetic resonance imaging of choroidal melanoma]. Yan Ke Xue Bao (1990) 0.78
Telomerase activity is found in the epithelial cells but not in the stromal cells in human endometrial cell culture. Mol Hum Reprod (1998) 0.77
A diagnostic system using broad categories with clinically relevant specifiers: lessons for ICD-11. Int J Soc Psychiatry (2010) 0.76
[Function of one novel gene identified by SSH PCR differentially expressed in HBX transfected HepG2 cells]. Zhonghua Yi Xue Za Zhi (2000) 0.76
p53 and WAF1 polymorphisms in Jewish-Israeli women with epithelial ovarian cancer and its association with BRCA mutations. BJOG (2000) 0.76
Surgical complications and outcome of pediatric liver transplantation in Hong Kong. J Pediatr Surg (2002) 0.76
Comment on "Editorial: The role of androgens in women". J Clin Endocrinol Metab (2001) 0.75
Thoughts of self-harm in terminally ill patients. Palliat Med (1998) 0.75
Paracetamol overdose. Br J Psychiatry (1996) 0.75
Single nucleotide polymorphism analysis on chicken extracellular fatty acid binding protein gene and its associations with fattiness trait. Sci China C Life Sci (2001) 0.75
Accuracy in air leak measuring. Isr Med Assoc J (2004) 0.75
Multiple personality disorder following childbirth. Br J Psychiatry (1993) 0.75